Clinical Trials Arena on MSN4d
INOVIO’s Covid-19 dMAb maintains in-vivo detection in 100% participantsResults saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAB in their systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback